These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
101 related items for PubMed ID: 1531987
1. Evaluation of the inotropic function at rest and the effect of enoximone in heart transplanted recipients. Assessment by left ventricular endsystolic pressure volume relationship. Heublein B, Auricchio A, Wagenbreth I, Haverich A, Dieterich HA. J Cardiovasc Surg (Torino); 1992; 33(1):21-7. PubMed ID: 1531987 [Abstract] [Full Text] [Related]
2. Enoximone: true inotropic effects? Do they cause ischemia? Analysis of end-systolic pressure-volume relations using the conductance (volume) catheter technique. Thormann J, Hueting J, Kremer P, Wissemann J, Mitrovic V, Dieterich HA, Schlepper M. Cardiovasc Drugs Ther; 1990 Oct; 4(5):1403-15. PubMed ID: 2149060 [Abstract] [Full Text] [Related]
3. Inotropic effect of enoximone in patients with severe heart failure: demonstration by left ventricular end-systolic pressure-volume analysis. Herrmann HC, Ruddy TD, William G, Strauss HW, Boucher CA, Fifer MA. J Am Coll Cardiol; 1987 May; 9(5):1117-23. PubMed ID: 2952702 [Abstract] [Full Text] [Related]
4. Low-dose enoximone in subjects awaiting cardiac transplantation. Clinical results and effects on beta-adrenergic receptors. Lee HR, Hershberger RE, Port JD, Rasmussen R, Renlund DG, O'Connell JB, Gilbert EM, Mealey PC, Volkman K, Menlove R. J Thorac Cardiovasc Surg; 1991 Aug; 102(2):246-58. PubMed ID: 1650867 [Abstract] [Full Text] [Related]
5. Comparison between the positive inotropic effects of enoximone, a cardiac phosphodiesterase III inhibitor, and dobutamine in patients with moderate to severe congestive heart failure. A study using the end-systolic pressure-volume relationship method. Installe E, De Coster P, Gonzalez M, Brichant C, Lessire H, Cauwe F. Eur Heart J; 1991 Sep; 12(9):985-93. PubMed ID: 1834466 [Abstract] [Full Text] [Related]
6. Proof for piroximone's inotropic influence; can it safely be used in coronary artery disease? Analysis of end-systolic pressure-volume relations (conductance technique). Thormann J, Liebrich A, Mitrovic V, Strasser R, Dieterich HA, Schlepper M. J Cardiovasc Pharmacol; 1992 Jul; 20(1):50-62. PubMed ID: 1383631 [Abstract] [Full Text] [Related]
14. Diastolic function in patients with severe heart failure: comparison of the effects of enoximone and nitroprusside. Herrmann HC, Ruddy TD, Dec GW, Strauss HW, Boucher CA, Fifer MA. Circulation; 1987 Jun; 75(6):1214-21. PubMed ID: 2952373 [Abstract] [Full Text] [Related]
15. [Is the bradycardic effect of tedisamil at the expense of the loss of the inotropic effect? A pressure-volume analysis with the conductance (volume) catheter technique in patients with coronary artery disease]. Thormann J, Mitrovic V, Strasser R, Pitschner HF, Riedel H, Bahavar H, Schlepper M. Z Kardiol; 1993 Apr; 82(4):211-21. PubMed ID: 8506715 [Abstract] [Full Text] [Related]
18. [End-systolic pressure-volume relationships obtained by conductance catheter and transient inferior vena caval occlusion: their clinical usefulness]. Kameyama T, Asanoi H, Ishizaka S, Nozawa T, Fujita M, Sasayama S. J Cardiol; 1991 Apr; 21(2):473-80. PubMed ID: 1668750 [Abstract] [Full Text] [Related]
19. [Use of enoximone in patients with acute and subacute heart failure in the intensive care unit]. Holubarsch C, Pieske B, Hasenfuss G, Just H. Z Kardiol; 1994 Apr; 83 Suppl 2():21-5. PubMed ID: 8091821 [Abstract] [Full Text] [Related]